[Changes in the cardiac valvular apparatus in patients with end-stage chronic renal failure on long-term programmed

Terapevticheskii Arkhiv
|February 13, 2003
PubMed

Insights

Chronic renal failure (CRF) patients on hemodialysis show distinct cardiac valve disease patterns. Younger patients experience mitral issues linked to mineral imbalances, while older patients develop aortic calcification, posing heart failure risks.

Area of Science:

  • Nephrology
  • Cardiology
  • Biochemistry

Background:

  • Chronic renal failure (CRF) significantly impacts cardiovascular health.
  • Programmed hemodialysis is a common treatment for CRF, but its long-term effects on cardiac and bone health require further investigation.
  • Understanding the specific sequelae of CRF on heart valves and bone density is crucial for patient management.

Purpose of the Study:

  • To investigate the specific features of cardiac valvular diseases in CRF patients undergoing programmed hemodialysis.
  • To analyze concurrent biochemical changes in blood composition.
  • To assess alterations in bone tissue density in these patients.

Main Methods:

  • A study involving 118 patients with CRF, divided into two age groups: 18-40 years (n=69) and 55-73 years (n=49).
  • Examination of cardiac valvular status, blood biochemical markers, and bone tissue density.
  • Comparative analysis between the younger and older patient cohorts.

Main Results:

  • Mitral valvular prolapse/disease was prevalent in younger patients (Group 1), associated with significant phosphorus and calcium metabolic disturbances and elevated parathyroid hormone levels.
  • Aortic valvular disease and cardiac tissue calcification were observed in older patients (Group 2).
  • These findings highlight age-dependent differences in cardiovascular complications of CRF.

Conclusions:

  • The observed patterns of cardiac valvular disease and metabolic changes are characteristic of CRF managed with programmed hemodialysis.
  • These conditions represent significant risk factors for developing chronic heart failure, particularly in elderly CRF patients.
  • Early identification and management of these risks are essential for improving outcomes in CRF patients.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...